Douglas Pharma Of New Zealand Gets U.S. Approval For Acne Drug
This article was originally published in PharmAsia News
New Zealand’s Douglas Pharmaceuticals said its Myorisan (isotretinoin) acne drug has received marketing clearance in the U.S. where the market is estimated to be worth $400 million.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.